STAAR Surgical Company in its $1.5 billion all-cash acquisition by Alcon Inc.

On August 4, 2025, STAAR Surgical Company (NASDAQ: STAA), the manufacturer of the proprietary Implantable Collamer® Lens for vision correction, entered into a definitive merger agreement to be acquired by Alcon (SIX/NYSE: ALC) in an all-cash transaction for approximately $1.5 billion.

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to STAAR Surgical Company.